Laura M Amodeo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Herein, we describe the generation and characterization of BI 655066, a novel, highly potent neutralizing anti-interleukin-23 (IL23) monoclonal antibody in clinical development for autoimmune conditions, including psoriasis and Crohn's disease. IL23 is a key driver of the differentiation, maintenance, and activity of a number of immune cell subsets,(More)
  • 1